Expression data were used to determine whether TMEM230 was also differentially expressed in glial tumor tissue cells from patients with low- or high-grade ODG or GBM (Figure 5 and Figure 6 and Supplementary Table S1). Here, TMEM230 is linked to glioblastoma.